Safety and Efficacy Study of Brimonidine in Patients With Glaucoma or Ocular Hypertension

Completed · Phase 3

Conditions studied: Glaucoma, Ocular Hypertension

In brief

This study evaluates the safety and efficacy of brimonidine 0.1% ophthalmic solution compared with brimonidine 0.2% ophthalmic solution in patients with glaucoma or ocular hypertension

Key facts

Study ID

NCT00652483

Run by

Allergan

People needed

433

Starts

2003-05-01

Expected to finish

2004-09-01

Last updated by the study team

2008-04-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ocular hypertension or glaucoma in both eyes

You may not qualify if…

• Uncontrolled systemic disease
• Known allergy or sensitivity to brimonidine

Where it is running

• Study site — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.